Are external loop recorders more cost-effective than Holter monitoring for ambulatory monitoring of "community acquired" syncope?
The net benefit regression framework provides a straightforward method for constructing cost-effectiveness acceptability curves in clinical trials.
The NBRF is straightforward to use and interpret. The resulting uncertainty surrounding the regression coefficient relates to the CEAC. When the link from the regression's p-value to the probability of cost-effectiveness is tentative, bootstrapping may be used.
Hoch et al. (Wed,) studied this question.